Y. Xiong

Safety of Recombinant Fusion Protein ESAT6-CFP10 as a Skin Test Reagent for Tuberculosis Diagnosis: an Open-Label, Randomized, Single-Center Phase I Clinical Trial

Feng Li, Xiaoyong Fan, Shuihua Lu, 2016, Clinical and Vaccine Immunology.

Safety, tolerability, pharmacokinetic characteristics, and immunogenicity of MW33: a Phase 1 clinical study of the SARS-CoV-2 RBD-targeting monoclonal antibody

Hongzhou Lu, Yan Lu, Xianmin Meng, 2021, Emerging microbes & infections.

Recombinant fusion ESAT6-CFP10 immunogen as a skin test reagent for tuberculosis diagnosis: an open-label, randomized, two-centre phase 2a clinical trial.

X. Fan, S. Lu, Shuihua Lu, 2016, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Determination of Lipoprotein Z-Specific IgA in Tuberculosis and Latent Tuberculosis Infection

Guoping Zhao, P. Ji, Yingying Chen, 2017, Front. Cell. Infect. Microbiol..

Mycobacterial Lipoprotein Z Triggers Efficient Innate and Adaptive Immunity for Protection Against Mycobacterium tuberculosis Infection

Y. Liu, Guoping Zhao, P. Ji, 2019, Front. Immunol..